QurieGen

I’m truly honored to be a part of the panel at the PHASE conference, where we’ll be diving deep into the transformative potential of AI in drug discovery. Looking forward to the discussion with some of the leading minds in the field. Don’t miss it! 📅 28.08 | 🕒 15:00 PHASE Conference: AI Drug Discovery - Where to Find Value? #AI #biotech #innovation #drugdiscovery #deeptech #pharma

Thrilled to announce that our CEO, Kinga Matuła, is joining top industry leaders at #PHASE2024 on August 28th to discuss the real potential of AI in transforming biotech. With the drug discovery and development market booming, it's time to cut through the hype and uncover where the real value lies. Stay tuned for insights!💡 Free registration here: www.pha-se.pl/ #AIinPharma #drugdevelopment #biotechinnovation

Exciting News in AI Drug Discovery! Recursion, a leader in AI-powered drug discovery, announced an agreement to acquire fellow biotech company Exscientia in a $688 million all-stock deal. This strategic move strengthens Recursion's position in the field by combining their expertise in biological target identification with Exscientia's strength in AI-driven drug design. The resulting powerhouse is poised to accelerate the development of new treatments, potentially saving both time and money and, furthermore, it validates the strength and resilience of the biotech sector.

Flagship Pioneering is doubling down on its mission to revolutionize healthcare and sustainability. With a $3.6 billion capital injection, this innovative biotech powerhouse is set to create a wave of ground-breaking companies and is poised to accelerate the development of life-changing solutions. This news is a resounding testament to the immense potential of biotech,  sustainability, artificial intelligence and the growing investor confidence in the sector. We are excited to see how Flagship's global footprint will fuel ground-breaking discoveries and drive positive impact! #biotech #innovation #AI #sustainability #healthcare #investment #futureofmedicine

🥇 We did it! Last week, QurieGen was crowned as the winner at the Global Deep Tech Startup Competition at the Extreme Tech Challenge and TNW Conference held in Amsterdam. The award is a great honour for our entire team, and we're incredibly grateful for the recognition from the judges present at the final pitch Marcus Hølland Eikeland, Andy Lurling, and Thomas Oehl. 🚀 This is a huge validation of our work towards redefining drug discovery and development, and we're even more motivated to keep pushing the boundaries in BioTech. #QurieGen #XTC #TWN #Winner #BioTech #DrugDiscovery #FutureofMedicine

It is today! Meet our CEO Kinga Matuła at TNW. We are super excited that QurieGen has been selected as one of the Top 5 Finalists for the Global Deep Tech Startup Competition at the TNW Conference! Please join us and the other finalists during the pitching competition judged by Marcus Hølland Eikeland (Katapult), Andy Lurling (LUMO Labs), and Thomas Oehl (Vsquared Ventures), hosted by Secorro Green. Finalists: 🧬QurieGen (Netherlands): AI-driven software to accelerate drug discovery through patented single-cell technology ⚡️Calectra (US): Low-cost electrification of high-temperature industrial heat via thermal storage; therefore, reducing the CO2 emissions of industrial production process 👩 Matrix Health & Care (UK): AI-based digitally-enabled device designed for gynecological self-examination 💻 Parrots AI (US): AI/ML neurocare solutions platform providing voice and telecare to people with neurological disorders ༄ REBLADE (Denmark): Wind turbine blade repair drone 📅 June 20, 2024 🕓 4:20-5:00 pm CET ⭐ Growth Quarters Stage | TNW Conference Please drop a comment or DM Kinga to book a meeting slot and discuss more at TNW! Hope to see you all at TNW! 🙌

📣 We are thrilled to announce that QurieGen has been selected as one of the Top 5 Finalists for the Global Deep Tech Startup Competition at the TNW Conference! Congratulations to the other incredible finalists!👏 ⚡ Calectra (U.S.) ♀ Matrix Health & Care (U.K.) 🚀 Parrots AI (U.S.) ༄ REBLADE (Denmark) 🌍 This truly is a global competition! Join us at the TNW to support us!

🎉 Happy International Women's Day! 🌟 🌷 As we mark International Women's Day, we celebrate the remarkable female founders who are shattering barriers and introducing innovative solutions to the forefront! 🎉 Our CEO Kinga Matuła has been spotlighted in a recent post by ScaleNL NL. Swipe below to read more. Let's continue to support women in entrepreneurship, leadership, and beyond. Together, we can create a more inclusive and diverse startup ecosystem. ✨

🚀 Concluding an inspiring week at the HealthTech Mini-Accelerator in Los Angeles! 🚀 After an intense week, we returned to the Netherlands armed with fresh insights and renewed inspiration to enhance our offerings for the US market. Here's a snapshot of the incredible moments from this week: ⚕ A visit to the Cedar’s Sinai Women’s Guild Simulation Center: A cutting-edge training facility for medical staff. Cedars-Sinai, one of the largest nonprofit academic medical centers in the U.S., has consistently been recognized as one of America’s Best Hospitals by U.S. News & World Report. With a track record of excellence and 20 consecutive years of receiving the National Research Corporation’s Consumer Choice Award for providing the highest quality medical care in LA, Cedars-Sinai is truly a beacon of innovation in healthcare. 🤝 One-on-one mentorship meetings with medical doctors and researchers. ⭐ Numerous expertise sessions covering various aspects of the US healthcare payer landscape, market structure, FDA regulations, electronic medical records, interoperability standards, and understanding liability risks. A big thank you to all the speakers - Tricia Ross Pearce, Keren Dunn, Doug Sturnick, Roshana Ahmed, Mike Thompson, Wenyue Du, PhD, CLP, Jeffrey Golden, Ray Duncan, Doug Sturnick, Ritesh Agarwal, Maureen Burgess, Patrick Callaghan, Robin, Tejal S. Patel, Esq. We extend our heartfelt gratitude to The Cedars-Sinai Accelerator the Cedars-Sinai Sinai mentors, ScaleNL, and NBSO Los Angeles teams for their impeccable organization, insightful guidance, and warm hospitality! Special thanks to Jim Laur, Pamela Collingwood, Samantha Shobash, Omar Perez, Nirdesh K Gupta, PhD, Rithik Jain, Michael D., Kaoutar Ashour, and Peter Post. A big shoutout to the other innovators who shared this journey with us - meeting you was truly a blast: Per Slycke and Mark van de Vrede from Loop Robots, Bart Geerts from Healthplus.ai, Aamer Ahmed A. from HEMEO, Pieter Smakman from Manometric, Ksenia Belkina from Cardiomo, Jord Budding from Richard van de Wateringen from Implant Preservation, Saber Amin Yavari from Preimure, Egbert Smit, and Haley Baptist from MLA Diagnostics. Last but certainly not least: this incredible journey wouldn't have been possible without the support from FEM-START 🙏 Cheers to pioneering new paths, fostering enduring relationships, and revolutionizing healthcare, step by step!

Exciting start to the Cedar Accelerator program today in Los Angeles! 🚀 Thank you Cedars-Sinai, ScaleNL and NBSO Los Angeles for hosting us!